(Total Views: 827)
Posted On: 11/07/2025 6:16:08 AM
Post# of 158771
This is pretty amazing stuff from Pestell, Burger and Lindner et al.
Example:
If Leron can reduce metastases by 87%, it should be part of standard adjuvant procedure in all solid tumor cancers. And that is not even considering the PD-L1 heightening effect.
Many thanks to Brentie for finding this.
Example:
Quote:
Leronlimab reduced CD4+CD25- cells (1.84-fold reduction, p=0.033). In the orthotopic colon cancer model, lung metastatic burden was decreased ~87% in leronlimab-treated mice compared to IgG-treated animals (p=0.012).
If Leron can reduce metastases by 87%, it should be part of standard adjuvant procedure in all solid tumor cancers. And that is not even considering the PD-L1 heightening effect.
Many thanks to Brentie for finding this.
(24)
(0)
